UBTD2, a member of the ubiquitin-proteasome system, is implicated in the regulation of protein degradation and cellular signaling pathways through its ubiquitin-related functions. The activity of UBTD2 can be influenced by a variety of chemical compounds, mainly through the modulation of signaling pathways and cellular states that indirectly impact its functional role. For instance, compounds that increase cyclic AMP (cAMP) levels can enhance the ubiquitination process that UBTD2 is part of, due to the cAMP-dependent protein kinase A (PKA) activation which can phosphorylate substrates and regulators involved in ubiquitination. Similarly, agents that elevate intracellular calcium levels can activate calcium-dependent proteases and kinases, potentially influencing the proteins that interact with UBTD2, thereby modulating its activity. Moreover, alterations in the cellular energetic state, such as those induced by the inhibition of ATP synthase, may lead to compensatory mechanisms that indirectly increase the activity of UBTD2, as cells attempt to regulate their protein and energy homeostasis.
Furthermore, the cellular balance of protein phosphorylation and dephosphorylation is also a critical determinant of UBTD2 activity. Compounds that inhibit protein phosphatases can shift this balance, consequently influencing pathways that UBTD2 may regulate or be involved with. In addition, the inhibition of specific kinases that are upstream of signaling pathways can lead to the activation of alternative mechanisms that could upregulate the ubiquitination process where UBTD2 plays a role. The impact of antioxidants on signaling pathways may also have a role in the modulation of UBTD2, as they can influence the cellular response to oxidative stress and the subsequent signaling cascades that govern protein maintenance and degradation. Lastly, the availability of NAD+ precursors can affect sirtuin activity, which is known to play a part in the regulation of protein post-translational modifications, and thus could impact the functional dynamics of UBTD2 within the cell.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
Non-specific inhibitor of phosphodiesterases, elevating cAMP by preventing its degradation, potentially augmenting UBTD2. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activator of protein kinase C (PKC) which could enhance phosphorylation states that favor UBTD2 activity. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Increases intracellular calcium levels, which may activate calcium-dependent pathways involving UBTD2. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
Calcium ionophore that increases cytosolic calcium, potentially modulating calcium-sensitive pathways interacting with UBTD2. | ||||||
Oligomycin A | 579-13-5 | sc-201551 sc-201551A sc-201551B sc-201551C sc-201551D | 5 mg 25 mg 100 mg 500 mg 1 g | $179.00 $612.00 $1203.00 $5202.00 $9364.00 | 26 | |
Inhibits ATP synthase, altering cellular energy states, which could indirectly upregulate UBTD2 activity. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
Proteasome inhibitor that could lead to accumulation of ubiquitinated proteins, thereby enhancing UBTD2's functional role. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Inhibits GSK-3, which may lead to activation of pathways that upregulate the activity of UBTD2. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Inhibitor of protein phosphatases 1 and 2A, altering phosphorylation balance and potentially increasing UBTD2 activity. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
Antioxidant that may influence signaling pathways associated with proteostasis, thereby modulating UBTD2 activity. | ||||||
Sodium Orthovanadate | 13721-39-6 | sc-3540 sc-3540B sc-3540A | 5 g 10 g 50 g | $49.00 $57.00 $187.00 | 142 | |
Inhibitor of protein tyrosine phosphatases, which could enhance tyrosine phosphorylation related to UBTD2 pathways. | ||||||